Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1001 to 1050 of 3228 in total 
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1001\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lysosomal acid lipase/cholesteryl ester hydrolase precursor (ec 3.1.1.13) (lal) (acid cholesteryl ester hydrolase) (sterol esterase) (lipase a) (cholesteryl esterase). [source:swissprot;acc:p38571]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5680.76\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6220.45\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.095\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1002\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
seryl-trna synthetase, mitochondrial precursor (ec 6.1.1.11) (serine--trna ligase) (serrsmt). [source:swissprot;acc:q9np81]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1003\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
seryl-trna synthetase (ec 6.1.1.11) (serine--trna ligase) (serrs). [source:swissprot;acc:p49591]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1004\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
o-sialoglycoprotein endopeptidase. [source:refseq;acc:nm\_017807]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5391.64\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5903.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09498\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1005\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
annexin a7 (annexin vii) (synexin). [source:swissprot;acc:p20073]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5780.34\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6329.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09497\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1006\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
peripheral plasma membrane protein cask (ec 2.7.1.-) (hcask) (calcium/calmodulin-dependent serine protein kinase) (lin-2 homolog). [source:swissprot;acc:o14936]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5707.73\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6249.1\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09485\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1007\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hypoxia-inducible factor-3 alpha isoform a; inhibitory pas domain protein. [source:refseq;acc:nm\_152794]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1008\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
single-minded homolog 1. [source:swissprot;acc:p81133]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1009\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
synapsin iii. [source:swissprot;acc:o14994]\vspace{3pt}}&\multirow{13}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5791.82\vspace{3pt}}}&\multirow{13}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6340.86\vspace{3pt}}}&\multirow{13}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0948\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1010\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
aspartate beta-hydroxylase isoform b; junctin isoform 1; junctate; aspartyl/asparaginyl-beta-hydroxylase; peptide-aspartate beta-dioxygenase; humbug. [source:refseq;acc:nm\_032468]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1011\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hairy/enhancer-of-split related with yrpw motif 1 (hairy and enhancer of split related-1) (hesr-1) (cardiovascular helix-loop-helix factor 2) (hes-related repressor protein 2 herp2). [source:swissprot;acc:q9y5j3]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1012\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
actin binding lim protein 2. [source:refseq;acc:nm\_032432]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1013\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hairy/enhancer-of-split related with yrpw motif-like. [source:refseq;acc:nm\_014571]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1014\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
synapsin ii. [source:swissprot;acc:q92777]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1015\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial ribosome recycling factor. [source:refseq;acc:nm\_138777]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1016\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
peroxisomal targeting signal 1 receptor (peroxismore receptor 1) (peroxisomal c-terminal targeting signal import receptor) (pts1-bp) (peroxin-5) (pts1 receptor). [source:swissprot;acc:p50542]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1017\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hairy/enhancer-of-split related with yrpw motif 2; gridlock; hes-related repressor protein 1. [source:refseq;acc:nm\_012259]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1018\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor hes-1 (hairy and enhancer of split 1) (hairy- like) (hhl) (hairy homolog). [source:swissprot;acc:q14469]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1019\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
delta3,5-delta2,4-dienoyl-coa isomerase, mitochondrial precursor (ec 5.3.3.-). [source:swissprot;acc:q13011]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1020\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
actin-binding lim protein 1 isoform a; lim actin-binding protein 1; limatin; actin-binding lim protein. [source:refseq;acc:nm\_002313]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1021\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
synapsin i (brain protein 4.1). [source:swissprot;acc:p17600]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1022\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein kinase clk2 (ec 2.7.1.-) (cdc-like kinase 2). [source:swissprot;acc:p49760]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6435.94\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7045.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09475\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1023\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein kinase clk3 (ec 2.7.1.-) (cdc-like kinase 3). [source:swissprot;acc:p49761]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6435.02\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7044.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09474\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1024\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cysteine-rich protein 1 (cysteine-rich intestinal protein) (crip) (cysteine-rich heart protein) (hcrhp). [source:swissprot;acc:p50238]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5706.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6245.55\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09446\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1025\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phosphomannomutase 2 (ec 5.4.2.8) (pmm 2). [source:swissprot;acc:o15305]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5511.96\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6031.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09434\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1026\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phosphomannomutase 1 (ec 5.4.2.8) (pmm 1) (pmmh-22). [source:swissprot;acc:q92871]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5509.89\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6029.29\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09427\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1027\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
s-adenosylmethionine synthetase gamma form (ec 2.5.1.6) (methionine adenosyltransferase) (adomet synthetase) (mat-ii). [source:swissprot;acc:p31153]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6123.15\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6700.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09422\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1028\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nicotinate-nucleotide pyrophosphorylase [carboxylating] (ec 2.4.2.19) (quinolinate phosphoribosyltransferase [decarboxylating]) (qaprtase) (qprtase). [source:swissprot;acc:q15274]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5704\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6241.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09421\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1029\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-catenin (pro2286). [source:swissprot;acc:p35222]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5635.26\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6166.09\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0942\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1030\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
casein kinase i, epsilon isoform (ec 2.7.1.-) (cki-epsilon) (ckie). [source:swissprot;acc:p49674]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5048.33\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5523.85\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09419\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1031\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
membrane protein expressed in epithelial-like lung adenocarcinoma. [source:refseq;acc:nm\_024792]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6136.99\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6714.98\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09418\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1032\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ran binding protein 11. [source:refseq;acc:nm\_016338]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6138.91\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6717.05\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1033\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fructose-1,6-bisphosphatase isozyme 2 (ec 3.1.3.11) (d-fructose-1,6- bisphosphate 1-phosphohydrolase) (fbpase). [source:swissprot;acc:o00757]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6080.91\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6653.52\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09417\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1034\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
s-adenosylmethionine synthetase alpha and beta forms (ec 2.5.1.6) (methionine adenosyltransferase) (adomet synthetase) (mat-i/iii). [source:swissprot;acc:q00266]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6152.88\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6732.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09414\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1035\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
casein kinase i, delta isoform (ec 2.7.1.-) (cki-delta) (ckid). [source:swissprot;acc:p48730]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5054.73\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5530.23\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09407\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1036\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fructose-1,6-bisphosphatase (ec 3.1.3.11) (d-fructose-1,6-bisphosphate 1-phosphohydrolase) (fbpase). [source:swissprot;acc:p09467]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6077.65\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6649.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09404\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1037\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
monoglyceride lipase; lysophospholipase-like. [source:refseq;acc:nm\_007283]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6544.26\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7159.43\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.094\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1038\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
myb proto-oncogene protein (c-myb). [source:swissprot;acc:p10242]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5417.95\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5924.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09348\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1039\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
myb-related protein b (b-myb). [source:swissprot;acc:p10244]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5418.92\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5923.09\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09304\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1040\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rna-binding region containing protein 2 (hepatocellular carcinoma protein 1) (splicing factor hcc1). [source:swissprot;acc:q14498]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5421.93\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5926.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09298\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1041\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
myb-related protein a (a-myb). [source:swissprot;acc:p10243]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5419.18\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5922.84\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09294\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1042\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
similar to lim domain only 7 (fragment). [source:sptrembl;acc:q8n6m2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5887.52\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6434.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09287\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1043\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
15 kda selenoprotein precursor. [source:swissprot;acc:o60613]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6344.41\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6933.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09283\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1044\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mbd2 (methyl-cpg-binding protein)-interacting zinc finger protein. [source:refseq;acc:nm\_015517]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4757.46\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5198.91\vspace{3pt}}&\multirow{7}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09279\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1045\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
immature colon carcinoma transcript 1 (digestion substraction 1) (ds- 1). [source:swissprot;acc:q14197]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5364.32\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5862.09\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1046\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
skeletal muscle tropomodulin (sk-tmod) (tropomodulin 4). [source:swissprot;acc:q9nzq9]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4757.46\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5198.91\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1047\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitous tropomodulin (u-tmod) (tropomodulin 3). [source:swissprot;acc:q9nyl9]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1048\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tropomodulin 1 (erythrocyte tropomodulin) (e-tmod). [source:swissprot;acc:p28289]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1049\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sorting nexin 9 (sh3 and px domain-containing protein 1) (sdp1 protein). [source:swissprot;acc:q9y5x1]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1050\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuronal tropomodulin (n-tmod) (tropomodulin 2). [source:swissprot;acc:q9nzr1]\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/